- Tytuł:
- 3MO Comprehensive biomarkers (BMS) analysis to predict efficacy of PD1/L1 immune checkpoint inhibitors (ICIs) in combination with chemotherapy: A subgroup analysis of the precision immuno-oncology for advanced non-small cell lung cancer (pioneer) trial
- Autorzy:
- Źródło:
- In Immuno-Oncology and Technology December 2022 16 Supplement 1
Czasopismo naukowe